✦ LIBER ✦

Pemetrexed: Single-agent and combination phase I study overview

✍ Scribed by Michael J. Boyer; Laurent P. Rivory; Stephen J. Clarke

Book ID: 114105477
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 71 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(02)70041-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of ALIMTA (pemetrexed dis

Phase II study of ALIMTA (pemetrexed disodium, MTA) single agent in patients with malignant pleural mesothelioma

✍ G. Scagliotti; D. Shin; H. Kindler; D. Johnson; U. Keppler 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 363 KB

576 Phase I dose-finding study of the co

576 Phase I dose-finding study of the combination of alimta (pemetrexed) and paclitaxel in patients with solid tumors

✍ D. Zingel; C. Bolling; T. Graefe; D. Radtke; J. Latz; J. Blatter; A.-R. Hanauske 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Pemetrexed single agent in previously tr

Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study

✍ BEARZ, A; GARASSINO, I; CAVINA, R; FAVARETTO, A; BOCCALON, M; TALAMINI, R; BERRE 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Designs for Single- or Multiple-Agent Ph

Designs for Single- or Multiple-Agent Phase I Trials

✍ Mark R. Conaway; Stephanie Dunbar; Shyamal D. Peddada 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Phase I and pharmacokinetic study (PK) o

Phase I and pharmacokinetic study (PK) of the combination of multitargeted antifolate pemetrexed (ALIMTA) with irinotecan (CPT-11) in patients with advanced malignancies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Single-agent carboplatinum for advanced

Single-agent carboplatinum for advanced seminoma a phase II study

✍ Hans-Joachim Schmoll; Andreas Harstrick; Carsten Bokemeyer; Klaus-Peter Dieckman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

Background. To reduce the side effects of cisplatinbased combination chemotherapy, the activity of carboplatinum was evaluated in patients with advanced seminoma. Methods. Forty-two evaluable patients with advanced seminoma (defined as abdominal lymph nodes > 5 cm or supradiaphragmatic or visceral